LG293 inhibitors (Lexicon)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameLG293 inhibitors (Lexicon)
Drug Alias Nameimmunosuppressant program (Lexicon)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEnzymes inhibitors
TargetsEnzymes
Therapy Area/IndicationsRejection of organ transplantationInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLexicon Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLexicon Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationInflammation

Other Information

ATC CodeN/A
Related LinksN/A